Phase III clinical trials that integrate treatment and biomarker evaluation
J Clin Oncol
.
2013 Sep 1;31(25):3158-61.
doi: 10.1200/JCO.2012.48.3826.
Epub 2013 Apr 8.
Authors
Boris Freidlin
1
,
Zhuoxin Sun
,
Robert Gray
,
Edward L Korn
Affiliation
1
National Cancer Institute, Bethesda, MD, USA. freidlinb@ctep.nci.nih.gov
PMID:
23569306
PMCID:
PMC3753704
DOI:
10.1200/JCO.2012.48.3826
No abstract available
MeSH terms
Biomarkers, Tumor / analysis*
Clinical Trials, Phase III as Topic*
Humans
Neoplasms / chemistry
Neoplasms / drug therapy*
Research Design*
Substances
Biomarkers, Tumor
Grants and funding
U10 CA023318/CA/NCI NIH HHS/United States